Back
Bone Biologics Corp. 10K Form
Sell
40
BBLG
Bone Biologics Corp.
Last Price:
$2.01
Seasonality Move:
-35.57%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BBLG News And Ratings
See the #1 stock for the next 7 days that we like better than BBLG
BBLG Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-591.4K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $3.35 |
| Price / Book: | 0.18 |
Profitability
| EPS (TTM): | -6.70690 |
|---|---|
| Net Income (TTM): | $-3.9M |
| Gross Margin: | $0 |
| Return on Equity: | -86.54% |
| Return on Assets: | -80.72% |
Bone Biologics Corp. Earnings Forecast
Key Bone Biologics Corp. Financial Ratios
-
Per Share Earnings over the last 14 years have been positive in 7 years.
Bone Biologics Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BBLG |
| Website: | bonebiologics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 19 |
| Quick Ratio: | 18.09 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BBLG Technical Analysis vs Fundamental Analysis
Sell
40
Bone Biologics Corp. (BBLG)
is a Sell
Is Bone Biologics Corp. a Buy or a Sell?
-
Bone Biologics Corp. stock is rated a SellThe current Bone Biologics Corp. [BBLG] share price is $2.03. The Score for BBLG is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.